Report - Statistical Analysis Plan - ClinicalTrials.gov · JKB-121 in treating subjects with biopsy-proven NASH. Subjects will be randomized at study entry to placebo twice daily, 5 mg twice

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form